No phaseStatus unknownHealthspan endpoint
Effect of skin barrier Strengthening on reducing inflammation in older adults with Psoriasis
Strengthening the skin barrier to reduce inflammatory mediators in older adults with Psoriasis: an interventional study
- Sponsor
- Faculdade de Medicina da Universidade de Brasília - UNB
- Enrolment
- 90 planned
- Conditions
- Psoriasis Skin and Connective Tissue Diseases
- Interventions
- This is a randomized, controlled, three-arm, double-blind clinical trial
- Ages
- adults, older adults
- Registry
- RBR-9mz4k5m
Full record on ReBECSource: WHO ICTRP, processed 3 August 2026
Primary outcomes
- To evaluate the progression of clinical and immunosenescence markers, including PASI score, circulating cytokine levels, telomere length, CDKN2 and TP53 gene expression, and the proportions of lymphocyte subpopulations, at baseline and at the end of the study.
History
Study completion expected
Last registry update
Started
Registered